This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Empros Pharma Ab. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Innovations by Anders Forslund in Obesity Treatment
Introduction
Anders Forslund is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of obesity and related metabolic disorders. With a total of 3 patents to his name, Forslund's work is recognized for its innovative approach to drug formulation.
Latest Patents
Forslund's latest patents focus on a modified-release composition that combines orlistat and acarbose. This composition is designed to address obesity and its associated metabolic disorders. The invention comprises distinct parts with varying release patterns, ensuring a more effective delivery of the active ingredients. Specifically, the composition includes: a first part, G1, containing from about 5 to about 70% w/w of the total dose of acarbose; a second part, G2A, comprising from about 30 to about 95% w/w of the total dose of acarbose; a third part, G2B, which includes from about 10 to about 90% w/w of the total dose of orlistat; and a fourth part, G3, containing from about 10 to about 80% w/w of the total dose of orlistat. The total concentration of acarbose and orlistat in the composition is 100% w/w.
Career Highlights
Forslund is currently associated with Empros Pharma AB, where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing effective treatments for obesity, a growing health concern worldwide.
Collaborations
Throughout his career, Forslund has collaborated with esteemed colleagues such as Göran Alderborn and Ulf Holmbäck. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Anders Forslund's contributions to the field of obesity treatment through his innovative patents highlight the importance of research and development in pharmaceuticals. His work continues to pave the way for more effective therapeutic options for individuals struggling with obesity and related metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile